FDA/CDC
FDA/CDC
Nearly one in five in U.S. still hadn’t gotten COVID by end of 2022
The CDC analyzed donor blood from 143,000 people every 3 months during 2022.
News
FDA approves talazoparib for metastatic prostate cancer
The new approval is based on findings from the randomized, placebo-controlled, phase 3 TALAPRO-2 trial.
FDA/CDC
CMS to cover Alzheimer’s drugs after traditional FDA okay
“If the FDA grants traditional approval, CMS is prepared to ensure anyone with Medicare Part B who meets the criteria is covered.”
News
FDA approves buprenorphine injection for opioid use disorder
Brixadi is approved in both weekly and monthly subcutaneous injectable formulations at varying doses.
Latest News
FDA OKs spinal cord stimulation devices for chronic back pain
The indication for the devices now includes treatment of chronic back pain in patients who have not had, or are not eligible for, back surgery.
Latest News
CDC: Drug-resistant ringworm reported in New York
BY ALICIA AULT
The
FDA/CDC
FDA approves first drug to treat Alzheimer’s agitation
“Agitation is one of the most common and challenging aspects of care among patients with dementia due to Alzheimer’s disease.”
Conference Coverage
New drugs in primary care: Lessons learned from COVID-19
Nirmatrelvir-ritonavir has helped keep many patients out of the hospital, says internist.
Latest News
FMT in a pill: FDA approves second product to prevent C. diff recurrence
Clinicians now have two approved options for recurrent infections after antibiotic treatment.
FDA/CDC
U.S. syphilis cases reach 70-year high
In just a 1-year period, from 2020 to 2021, cases increased by 32%.